VIVUS, Inc.

Website Links

Description

VIVUS was incorporated in California on April 16, 1991 and completed a re-incorporation in the state of Delaware in May 1996.

VIVUS is dedicated to bringing education and awareness of our clinical trials to patient and healthcare communities.

The effect of Qsymia on cardiovascular morbidity and mortality has not been established. The safety and effectiveness of Qsymia in combination with other products intended for weight loss, including prescription and over-the-counter drugs, and herbal preparations, have not been established.

Mark B. Logan has served as a Director of the Company since March 1999 and served as Chairman of the Board through July 2013. From November 1994 until his retirement in 2001, Mr. Logan served as Chairman and Chief Executive Officer of VISX, Inc. Mr. Logan was also Chairman, President and Chief Executive Officer of Insmed Pharmaceuticals, Inc., where he served on its board since its founding in 1988. Prior to Insmed, Mr. Logan was a principal at McManus Associates, Inc., and prior to that served as Executive Vice President, Chief Operating Officer, and as a member of the board of Bausch & Lomb.

Fact sheet

Company contacts

Companies nearby